2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular …

S Halvorsen, J Mehilli, S Cassese, TS Hall… - European heart …, 2022 - academic.oup.com
Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Ehra expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the heart rhythm society (hrs), asia pacific heart rhythm society …

I Savelieva, S Fumagalli, RA Kenny, S Anker… - Europace, 2023 - academic.oup.com
There is an increasing proportion of the general population surviving to old age with
significant chronic disease, multi-morbidity, and disability. The prevalence of pre-frail state …

Prevention of complications in the cardiac intensive care unit: a scientific statement from the American Heart Association

CB Fordyce, JN Katz, CL Alviar, C Arslanian-Engoren… - Circulation, 2020 - Am Heart Assoc
Contemporary cardiac intensive care units (CICUs) have an increasing prevalence of
noncardiovascular comorbidities and multisystem organ dysfunction. However, little …

2023 HRS expert consensus statement on the management of arrhythmias during pregnancy

JA Joglar, S Kapa, EV Saarel, AM Dubin, B Gorenek… - Heart Rhythm, 2023 - Elsevier
This international multidisciplinary expert consensus statement is intended to provide
comprehensive guidance that can be referenced at the point of care to cardiac …

Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review

J Hartnett, W Jaber, M Maurer, B Sperry, M Hanna… - Cardio Oncology, 2021 - jacc.org
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by the extracellular
deposition of amyloid fibrils in the myocardium. Although cardiac amyloidosis patients …

The role of amiodarone in contemporary management of complex cardiac arrhythmias

N Mujović, D Dobrev, M Marinković, V Russo… - Pharmacological …, 2020 - Elsevier
Amiodarone is an iodinated benzofuran derivative, a highly lipophilic drug with
unpredictable pharmacokinetics. Although originally classified as a class III agent due to its …

[HTML][HTML] Ventricular arrhythmias in ischemic cardiomyopathy—new avenues for mechanism-guided treatment

M Amoni, E Dries, S Ingelaere, D Vermoortele… - Cells, 2021 - mdpi.com
Ischemic heart disease is the most common cause of lethal ventricular arrhythmias and
sudden cardiac death (SCD). In patients who are at high risk after myocardial infarction …

[HTML][HTML] Estándares SEA 2019 para el control global del riesgo cardiovascular

JM Mostaza, X Pintó, P Armario, L Masana… - Clínica e Investigación …, 2019 - Elsevier
Resumen La Sociedad Española de Arteriosclerosis tiene entre sus objetivos contribuir al
mayor y mejor conocimiento de la enfermedad vascular, su prevención y su tratamiento. Las …

Comorbidity between epilepsy and cardiac arrhythmias: implication for treatment

G Zaccara, S Lattanzi - Epilepsy & Behavior, 2019 - Elsevier
Epilepsy is often comorbid with either neurological or nonneurological diseases. The
association between epilepsy and cardiac arrhythmias is not infrequent, mostly in patients …